Furthermore, a cathepsin K inhibitors reduced the urinary CTX-II level in patients with osteoporosis [21] and showed a cartilage protective effect in several models of RA and osteoarthritis [22–25]. The gene discussed is CTSK; the disease is osteoporosis.